Related Experiment Video
Updated: Mar 7, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
A refractory polyarthritis revealing a multicentric reticulohistiocytosis
Océane Deville-Cavellin1, Angélique Nallet1, Stéphane Ralandison2
1IRMB, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, University of Montpellier, INSERM, Lapeyronie University Hospital, CHU Montpellier, Montpellier, France.
Abstract:
Multicentric reticulohistiocytosis is a rare, non-Langerhans cell histiocytosis characterised by papulonodular skin lesions and a rapidly progressive, erosive polyarthritis. We describe the case of a 51-year-old man who presented with a 6 months of acute inflammatory polyarthralgia, synovitis, and extensor tenosynovitis. Concurrently, multiple papulonodular lesions developed on his hands, face, and auricular regions. A skin biopsy demonstrated CD68-positive histiocytes and multinucleated giant cells with eosinophilic 'ground-glass' cytoplasm, confirming multicentric reticulohistiocytosis. Treatment with corticosteroids and methotrexate was ineffective, whereas tumour necrosis factor-alpha inhibitor therapy resulted in meaningful clinical improvement and steroid sparing. Early recognition, imaging, and a biopsy are essential to avoid irreversible joint damage. Although therapeutic evidence is limited to case reports, biologic agents targeting pro-inflammatory cytokines may offer a significant benefit. Awareness of multicentric reticulohistiocytosis is crucial for timely diagnosis and management.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Hypersensitivity Reactions: Immune-Complex Reactions

